Profiel
Richard Schoenfeld is Vice President of Operations for PharmAthene, Inc. He joined PharmAthene in October 2005.
He was Vice President of Supply Chain Management for EMD Pharmaceuticals and Senior Vice President of Engineering and Technology Development for Genzyme.
Mr. Schoenfeld held various positions at Endotronics and Monsanto.
He had 30 years of experience in developing and manufacturing proteins.
Mr. Schoenfeld received an Advanced Graduate Certificate in Business Ethics from Bentley College.
He received an MS and a PhD in Bioengineering from the Polytechnic Institute of Brooklyn, a BS in Chemical Engineering from Northeastern University and an MBA from St. Louis University.
Eerdere bekende functies van Richard Schoenfeld
| Bedrijven | Functie | Einde |
|---|---|---|
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Operationeel Directeur | 09-08-2007 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Corporate Officer/Principal | - |
Opleiding van Richard Schoenfeld
| Northeastern University | Undergraduate Degree |
| St. Louis University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Health Technology |
| Polytechnic University | Consumer Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |